Physician profile
David Andre Levi
NPI 1134160799
$3,598.94
in general payments reported to CMS, 2019-2025
18 companies · $603 in 2025
The $603 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $599 · 2021: $711 · 2022: $177 · 2023: $684 · 2024: $304 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,590.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $1,064.79 | 2019-2025 | Kristalose |
| Genzyme Corporation | $494.30 | 2021-2025 | |
| Pfizer INC. | $361.62 | 2019-2023 | |
| Glaxosmithkline, LLC. | $276.41 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $251.68 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Astrazeneca Pharmaceuticals Lp | $248.14 | 2021-2025 | Fasenra |
| Sobi, INC | $237.40 | 2019-2020 | |
| Seqirus USA INC | $132.63 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent, Fluad |
| Regeneron Healthcare Solutions, INC. | $126.09 | 2023-2025 | Dupixent |
| Cranial Technologies, INC | $105.46 | 2020-2025 | Doc Band |
| Sanofi Pasteur INC. | $68.50 | 2021-2024 | |
| Ars Pharmaceuticals Operations, INC. | $58.88 | 2025 | Neffy |
| Alk-Abello, INC | $54.92 | 2024-2025 | Neffy, Odactra, Ragwitek |
| Genentech USA, INC. | $42.54 | 2020-2021 | |
| Aytu Biopharma, INC. | $21.92 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $21.05 | 2024 | Voxzogo 1.2mg |
| Alexion Pharmaceuticals, INC. | $18.35 | 2019 | |
| Phadia US INC. | $14.26 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Levi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.